Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs1799945
rs1799945
0.100 GeneticVariation BEFREE To test whether genetic haemochromatosis is associated with myocardial infarction, we determined the prevalence of three mutations in the HFE gene (Cys282Tyr, His63Asp and Ser65Cys) in a 2 : 1 case-control study including 177 patients who survived an acute myocardial infarction and 89 controls. 11886425

2002

dbSNP: rs1799945
rs1799945
0.100 GeneticVariation BEFREE A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation. 11874997

2002

dbSNP: rs1799945
rs1799945
0.100 GeneticVariation BEFREE Analysis of HLA-A antigens and C282Y and H63D mutations of the HFE gene in Brazilian patients with hemochromatosis. 11887210

2002

dbSNP: rs1799945
rs1799945
0.100 GeneticVariation BEFREE A rare case of a patient heterozygous for the hemochromatosis mutation C282Y and homozygous for H63D. 11783952

2003

dbSNP: rs1799945
rs1799945
0.100 GeneticVariation BEFREE Our results show that the C282Y and H63D mutations of the HFE gene associated with hemochromatosis have measurable and consistent effects on iron indicators and are associated with liver disorders, but have no measurable effect on other iron overload-related symptoms and life-expectancy. 12678056

2003

dbSNP: rs1799945
rs1799945
0.100 GeneticVariation BEFREE Our study shows that the HFE C282Y and H63D are determinants of iron parameters in the elderly and will be effective in detecting individuals at high risk of hemochromatosis. 12673276

2003

dbSNP: rs1799945
rs1799945
0.100 GeneticVariation BEFREE Frequency of the HFE C282Y and H63D mutations in Danish patients with clinical haemochromatosis initially diagnosed by phenotypic methods. 14703688

2003

dbSNP: rs1799945
rs1799945
0.100 GeneticVariation BEFREE There are limited data on the frequency and biochemical expression of the haemochromatosis-associated mutations C282Y and H63D in healthy people. 14642607

2003

dbSNP: rs1799945
rs1799945
0.100 GeneticVariation BEFREE The mutations investigated here (C282Y, H63D and S65C) are often the mutation targets used in the genetic testing for haemochromatosis. 14737579

2004

dbSNP: rs1799945
rs1799945
0.100 GeneticVariation BEFREE Moreover, further studies are needed to elucidate the role of this mutation in the development of HH and the genetic, environmental or other factors that affect the genotype-phenotype correlation between H63D and hemochromatosis. 15727249

2004

dbSNP: rs1799945
rs1799945
0.100 GeneticVariation BEFREE Two specific, single point mutations of the HFE gene (C282Y and H63D) have been described in haemochromatosis patients. 15061375

2004

dbSNP: rs1799945
rs1799945
0.100 GeneticVariation BEFREE We found differences [using the chi-square (chi2) test] in the frequency of the H63D mutation between the control group and the group of hemochromatosis patients (p<0.01). 15517265

2005

dbSNP: rs1799945
rs1799945
0.100 GeneticVariation BEFREE Two sites of point mutations in the HFE gene, C282Y and H63D, are associated with more than 80% of haemochromatosis cases. 16419611

2005

dbSNP: rs1799945
rs1799945
0.100 GeneticVariation BEFREE Heterozygous beta-thalassemia and homozygous H63D hemochromatosis in a child: an 18-year follow-up. 15805002

2005

dbSNP: rs1799945
rs1799945
0.100 GeneticVariation BEFREE HFE-associated hemochromatosis (HH) defined as homozygosity for the C282Y (n = 14, 7.2%) mutation or compound heterozygosity for the C282Y/H63D (n = 11, 5.6%) mutation was identified in 12.8% of patients. 16083706

2005

dbSNP: rs1799945
rs1799945
0.100 GeneticVariation BEFREE Analysis of the hemochromatosis mutations C282Y and H63D in infertile men. 17067586

2006

dbSNP: rs1799945
rs1799945
0.100 GeneticVariation BEFREE We evaluated the associations of self-reported diabetes with serum ferritin concentration, transferrin saturation (TfSat), and HFE C282Y and H63D mutations in six racial/ethnic groups recruited at five field centers in the Hemochromatosis and Iron Overload Screening (HEIRS) study. 16936157

2006

dbSNP: rs1799945
rs1799945
0.100 GeneticVariation BEFREE To assess geographic differences in the frequencies of HFE C282Y and H63D genotypes in six racial/ethnic groups recruited in the Hemochromatosis and Iron Overload Screening (HEIRS) Study. 17061732

2006

dbSNP: rs1799945
rs1799945
0.100 GeneticVariation BEFREE The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis. 16979952

2006

dbSNP: rs1799945
rs1799945
0.100 GeneticVariation BEFREE Hemochromatosis and iron overload screening (HEIRS) Study is an ongoing, multiethnic, primary care-based study of 101,168 North American adults, including 12,772 Asians, a group that the HEIRS Study found has a significantly higher than expected prevalence of elevated serum TS and SF but very low prevalence of the common C282Y and H63D HFE alleles usually associated with hereditary hemochromatosis. 17240320

2007

dbSNP: rs1799945
rs1799945
0.100 GeneticVariation BEFREE Liver is the primary target organ of Hereditary Hemochromatosis Type I, with the HFE mutations C282Y and H63D recognized as markers of this iron-overload disease. 17428702

2007

dbSNP: rs1799945
rs1799945
0.100 GeneticVariation BEFREE She was heterozygous for the common H63D mutation of the hemochromatosis-associated HFE gene. 17919354

2007

dbSNP: rs1799945
rs1799945
0.100 GeneticVariation BEFREE Although hemochromatosis is associated with pancreatic pathology, the p.C282Y and p.H63D variants do not play a significant role in the pathogenesis of chronic pancreatitis or pancreatic adenocarcinoma. 17666895

2007

dbSNP: rs1799945
rs1799945
0.100 GeneticVariation BEFREE We studied 45 H63D homozygotes (31 males and 14 females) with biochemical iron overload and/or clinical features of haemochromatosis. 17042772

2007

dbSNP: rs1799945
rs1799945
0.100 GeneticVariation BEFREE We analyzed initial screening data in 7,343 HEmochromatosis and IRon Overload Screening (HEIRS) Study participants ages 25-29 years, including race/ethnicity and health information; transferrin saturation (TS) and ferritin (SF) measurements; and HFE C282Y and H63D genotypes. 17726683

2008